For people with atrial fibrillation (Afib or AF), stopping oral anticoagulation (OAC) after a "successful" catheter ablation ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...
Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
Triastek announces that on February 27, 2025 a proprietary 3D-printed non-vitamin K antagonist oral anticoagulant (NOAC) ...
Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...
A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results